What's new

Human medicines European public assessment report (EPAR): TachoSil, human fibrinogen,human thrombin, Date of authorisation: 08/06/2004, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): TachoSil, human fibrinogen,human thrombin, Date of authorisation: 08/06/2004, Revision: 27, Status: Authorised

Jun 17, 2025 - 16:25
 0
Human medicines European public assessment report (EPAR): TachoSil, human fibrinogen,human thrombin, Date of authorisation: 08/06/2004, Revision: 27, Status: Authorised
Human medicines European public assessment report (EPAR): TachoSil, human fibrinogen,human thrombin, Date of authorisation: 08/06/2004, Revision: 27, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Tecentriq, atezolizuma...

Next Article

Auterion signs MoU with Taiwan for drone swarming software

Related Posts

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0

Human medicines European public assessment report (EPAR): Vipdomet, alogliptin,metformin, Date of authorisation: 18/09/2013, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0

Human medicines European public assessment report (EPAR): Rytelo, imetelstat, Date of authorisation: 07/03/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0